NCT00047736View on ClinicalTrials.gov

A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2001

Study Completion Date

July 31, 2003

Conditions
Lung Cancer
Interventions
DRUG

Tarceva (erlotinib HCl)

Trial Locations (2)

Unknown

Multinational Sites, Denver

Trial Information Center, Denver

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00047736 - A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer | Biotech Hunter | Biotech Hunter